Loading...
Regulatory Uncertainty And 340B Pressures Will Erode Oncology Margins
AnalystLowTarget's Fair Value
US$36.00
7.1% overvalued intrinsic discount09 Aug
US$38.57
1Y
50.0%7D
-6.7%1Y
50.0%7D
-6.7%You can edit this narrative until May 18 10:09 PM. Then, changes will post as Updates.